Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 128 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 2214. Clear
Clear
Q2
STUMPTOWN STRATEGIES for PRIME THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · Minnesota · House · Senate · $20,000.00 income
Health Issues, Pharmacy
View →
Q2
HOOPER, LUNDY & BOOKMAN, P.C. for GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · Florida · House · Senate · $10,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
PRIME THERAPEUTICS for PRIME THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · Minnesota · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
2A
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q2
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
1A
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View →
Q1
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Taxation/Internal Revenue Code, Trade (domestic/foreign), Defense
View →
Q1
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Q1
CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Pharmacy, Taxation/Internal Revenue Code, Medicare/Medicaid, Insurance
View →
Q1
EMD SERONO, INC. for EMD SERONO INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Science/Technology, Trade (domestic/foreign), Health Issues, Medicare/Medicaid
View →
Q1
BANNER PUBLIC AFFAIRS, LLC for THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $20,000.00 income
Defense, Health Issues
View →
Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
AMGEN, INC. for AMGEN INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q1
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate
Alcohol and Drug Abuse, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q1
CAROL G HOLLADAY & ASSOCIATES for SOUTHEAST GEORGIA HOSPITAL SYSTEM
1st Quarter (Jan 1 - Mar 31) 2025 · Georgia · House · Senate · $18,000.00 income
Budget/Appropriations, Health Issues, Veterans, Pharmacy
View →
Q1
ELEVANCE HEALTH, INC. for ELEVANCE HEALTH, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Insurance, Medicare/Medicaid, Pharmacy
View →
Q1
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Defense, Pharmacy
View →
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
EMERGENT STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q1
PRIME THERAPEUTICS for PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Minnesota · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Pharmacy, Science/Technology, Taxation/Internal Revenue Code, Veterans
View →
Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
HOOPER, LUNDY & BOOKMAN, P.C. for GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Florida · House · Senate · $10,000.00 income
Medicare/Medicaid, Health Issues
View →
1A
RYAN COSTELLO STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income
Health Issues
View →
Previous Page 5 of 6 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem